The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BYSI | +21.09% | -87.93% | -34.45% | -88% |
| S&P | +13.19% | +87.83% | +13.42% | +185% |
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in New York, NY.
A lucrative partnership deal with a pharmaceutical giant in China bodes well for BeyondSpring's potential new blockbuster cancer drug.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.02M | 0.0% |
| Market Cap | $73.00M | 0.0% |
| Net Income | -$1.74M | 0.0% |
| EBITDA | -$1.77M | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $12.48M | 0.0% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.09M | 0.0% |
| Short Term Debt | $0.31M | 0.0% |
| Current | YOY Change | |
|---|---|---|
| Return On Invested Capital | 291.80% | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4.29M | 0.0% |
| Operating Free Cash Flow | -$4.29M | 0.0% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|
| Price to Book | -1.92 | -3.35 | -2.42 | - |
| Price to Tangible Book Value | -1.92 | -3.35 | -2.42 | - |
| Enterprise Value to EBITDA | -25.90 | -52.68 | -41.11 | - |
| Total Debt | $0.55M | $0.48M | $0.41M | - |
No podcast episodes available.
BYSI earnings call for the period ending March 31, 2022.
BYSI earnings call for the period ending June 30, 2021.
BYSI earnings call for the period ending March 31, 2021.
BYSI earnings call for the period ending March 31, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
